Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Jan Škvařil
AddedFeb 16, 2024
UpdatedMay 31, 2026
Jan Škvařil

Jan Škvařil

Co-Founder, RxDiet

CrunchbaseLinkedIn

Jan Škvařil's Career

RxDiet
RxDiet

New York City, NY, US

Co-Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Jan Škvařil's Career

RxDiet
RxDiet
$1.6M2021New York City, NY, US
Co-Founder

Recent news

RxDiet Raises $3M to Treat Chronic Illnesses with Medically Tailored Food PlansAlleyWatch · 2024
RxDiet Raises $3M for AI-Powered 'Food as Medicine' PlatformAthletech News · 2024
RxDiet Secures $3 Million Seed Round to drive down healthcare costs using AI-driven food as medicineBusiness Wire · 2024

Leadership at RxDiet

Roman KalistaRoman KalistaCo-Founder
Matthew ConettaMatthew ConettaCo-Founder

Similar to RxDiet

EatRxEatRxSebastopol, CA, USMeal Plans, Nutritionest. 2014EatRxSebastopol, CA, US · est. 2014

EatRx: Tailoring nutrient-rich meal plans for optimal health, without pharmaceutical side effects.

$1M6
NourishedRxNourishedRxStamford, CT, USFood Delivery, Health Foodest. 2019NourishedRxStamford, CT, US · est. 2019

NourishedRx: Personalized food solutions for health plan members with diet-sensitive conditions.

$6M41
Meal IQMeal IQLondon, Greater London, GBMeal Planning, Nutritionest. 2016Meal IQLondon, Greater London, GB · est. 2016

Meal IQ: Streamlining healthy eating with personalized meal plans, online grocery shopping, and nutrition advice.

$120k7
Elo HealthElo HealthSan Francisco, CA, USNutrition Plans, Supplementsest. 2021Elo HealthSan Francisco, CA, US · est. 2021

Elo: Transforming food into medicine through AI and biomarker-driven healthcare technology.

$15M41

People Similar to Jan Škvařil

Nugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakBo ZhangBo ZhangCo-Founder · DiDiWILL WEI CHENGWILL WEI CHENGCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniFounder · Reliance RetailBrian KimBrian KimCo-Founder · KakaoKim Beom-sooKim Beom-sooCo-Founder · KakaoJB LEEJB LEECo-Founder · KakaoDaniel AronovichDaniel AronovichCo-Founder · Vocalis HealthTyler MalinTyler MalinCo-Founder · Rdcl SuperfoodsKevin PfabKevin PfabCo-Founder · Emergent OneVictor CarreñoVictor CarreñoCo-Founder · Food for All